Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 91 Earnings per Share (Diluted) is $2.29 as of Dec. 2024. GuruFocus rates CGSBF with a GF Score™ of 91/100 and a GF Value™ of $43.12. Among 507 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 63.71% on this metric.
During the past 12 months, Corporativo FraguaB de CV's average EPS without NRIGrowth Rate was 9.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 23.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 25.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 18.80% per year.
During the past 13 years, Corporativo FraguaB de CV's highest 3-Year average EPS without NRI Growth Rate was 30.70% per year. The lowest was 2.30% per year. And the median was 14.40% per year.
Corporativo FraguaB de CV (OTCPK:CGSBF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Corporativo FraguaB de CV Earnings per Share (Diluted) Related Terms
Corporativo FraguaB de CV Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Corporativo FraguaB de CV's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV Earnings per Share (Diluted) Chart
Corporativo FraguaB de CV Earnings per Share (Diluted) Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's PE Ratio distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's PE Ratio falls into.
Corporativo FraguaB de CV Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Corporativo FraguaB de CV's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $2.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $2.29 mean?
Corporativo FraguaB de CV (CGSBF) has a Earnings per Share (Diluted) of $2.29 as of Dec. 2024. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Corporativo FraguaB de CV and its competitors. According to the industry distribution chart, Corporativo FraguaB de CV ranks #184 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 36.3%.
Is Corporativo FraguaB de CV's Earnings per Share (Diluted) too high?
Corporativo FraguaB de CV's current Earnings per Share (Diluted) is $2.29. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.30. Corporativo FraguaB de CV's value of $2.29 is 79.7% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #184 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's Earnings per Share (Diluted) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #184 out of 507 companies for Earnings per Share (Diluted). This puts Corporativo FraguaB de CV in the upper half of its industry. The industry median Earnings per Share (Diluted) is 11.30. Corporativo FraguaB de CV's value of $2.29 is 79.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.30, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current Earnings per Share (Diluted) of $2.29 is 79.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current Earnings per Share (Diluted) is $2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current Earnings per Share (Diluted) of $2.29. The stock's GF Value™ is $43.12, compared to a current price of $29.66 — trading 31.2% below its estimated fair value. The current Earnings per Share (Diluted) is $2.29 and 79.7% below the Healthcare Providers & Services industry median of 11.30. Corporativo FraguaB de CV's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current Earnings per Share (Diluted) is $2.29 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 31.2% below its estimated GF Value™ of $43.12.
Key valuation signals for CGSBF:
Earnings per Share (Diluted): $2.29
GF Value™: $43.12 vs. price of $29.66 (31.2% below fair value)
Industry Position: 79.7% below the Healthcare Providers & Services median (#184 of 507)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
91GF Score
Get the complete analysis for CGSBF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
